Crossmark

Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”

Crossref DOI link: https://doi.org/10.1007/s40121-022-00641-9

Published Online: 2022-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perdrizet, Johnna https://orcid.org/0000-0002-4260-7607
Horn, Emily https://orcid.org/0000-0002-2491-7134
Nua, Winniefer

Perez-Peralta, Judith

Nailes, Jennifer https://orcid.org/0000-0001-6334-0510
Santos, Jaime

Ong-Lim, Anna
License Information

Text and Data Mining valid from 2022-05-16

Version of Record valid from 2022-05-16
More Information

Article History

Received: 9 March 2022

Accepted: 11 April 2022

First Online: 16 May 2022